Atrium Therapeutics announces inducement grants under Nasdaq Rule 5635(c)(4)
Atrium Therapeutics (RNA) announces inducement grants under Nasdaq Listing Rule 5635(c)(4), per the company’s release.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.